Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Completed Phase 1 Trials for Mycophenolate mofetil (DB00688)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00988715Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeTreatment